Anti-TNF Receptor I antibody [EPR23742-65] - BSA and Azide free
- RabMAb
- Recombinant
- KO Validated
- What is this?
Be the first to review this product! Submit a review
|
(0 Publication)
Rabbit Recombinant Monoclonal TNF Receptor I antibody. Carrier free. Suitable for WB and reacts with Human samples.
View Alternative Names
CD120a, TNFAR, TNFR1, TNFRSF1A, Tumor necrosis factor receptor superfamily member 1A, Tumor necrosis factor receptor 1, Tumor necrosis factor receptor type I, p55, p60, TNF-R1, TNF-RI, TNFR-I
- WB
Lab
Western blot - Anti-TNF Receptor I antibody [EPR23742-65] - BSA and Azide free (AB283289)
This data was developed using ab259817, the same antibody clone in a different buffer formulation.
Blocking and diluting buffer and concentration : 3% NFDM/TBST
Lanes 1-3 : Merged signal (red and green). Green - ab259817 observed at 51 kDa. Red - loading control ab8245 (Mouse monoclonal [6C5] to GAPDH) observed at 36 kDa.
ab259817 Anti-TNF Receptor I antibody [EPR23742-65] was shown to specifically react with TNF Receptor I in wild-type HeLa cells. Loss of signal was observed when knockout cell line ab265972 (knockout cell lysate ab257751) was used. Wild-type and TNF Receptor I knockout samples were subjected to SDS-PAGE. ab259817 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated at 4°C overnight at 1 in 1000 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 10000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-TNF Receptor I antibody [EPR23742-65] (<a href='/en-us/products/primary-antibodies/tnf-receptor-i-antibody-epr23742-65-ab259817'>ab259817</a>) at 1/1000 dilution
Lane 1:
Wild-type HeLa (human cervix adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 2:
TNFRSF1A (TNF Receptor I) knockout HeLa (human cervix adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 2:
Western blot - Human TNFRSF1A (TNF Receptor I) knockout HeLa cell line (<a href='/en-us/products/cell-lines/human-tnfrsf1a-tnf-receptor-i-knockout-hela-cell-line-ab265972'>ab265972</a>)
Lane 3:
A549 (human lung carcinoma epithelial cell) whole cell lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG H&L (IRDye® 800CW) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-irdye-800cw-preadsorbed-ab216773'>ab216773</a>) and Goat Anti-Mouse IgG H&L (IRDye® 680RD) (<a href='/en-us/products/secondary-antibodies/goat-mouse-igg-h-l-irdye-680rd-preadsorbed-ab216776'>ab216776</a>) at 1/10000 dilution
Predicted band size: 50 kDa
Observed band size: 50-70 kDa
false
- WB
Lab
Western blot - Anti-TNF Receptor I antibody [EPR23742-65] - BSA and Azide free (AB283289)
This data was developed using ab259817, the same antibody clone in a different buffer formulation.
Blocking and diluting buffer and concentration : 5% NFDM/TBST
The difference in target band size observed in HeLa and HepG2 cell lysates is caused by glycosylation.
Negative control : Raji (PMID : 1966549; PMID : 2158104).
Exposure time : 81 seconds
All lanes:
Western blot - Anti-TNF Receptor I antibody [EPR23742-65] (<a href='/en-us/products/primary-antibodies/tnf-receptor-i-antibody-epr23742-65-ab259817'>ab259817</a>) at 1/1000 dilution
Lane 1:
HeLa (human cervix adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 2:
HepG2 (human hepatocellular carcinoma epithelial cell) whole cell lysate at 20 µg
Lane 3:
Raji (human Burkitt's lymphoma B lymphocyte) whole cell lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/50000 dilution
Predicted band size: 50 kDa
Observed band size: 50-70 kDa
false
Related conjugates and formulations (1)
-
Anti-TNF Receptor I antibody [EPR23742-65]
Reactivity data
Product details
ab283289 is the carrier-free version of ab259817.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com